Results
Akums Q1 Revenue Up 13.9% YoY, PAT Jumps 56.1%
Akums Drugs reported Q1 FY27 consolidated revenue of ₹1,167 crore, a 13.9% YoY growth, with PAT surging 56.1% to ₹101 crore.
The company announced the acquisition of Oriflame India's manufacturing bus